Nav: Home

Current Oncogene News and Events

Current Oncogene News and Events, Oncogene News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 14 | 522 Results
Oncotarget: Genomic markers of midostaurin drug sensitivity in leukemia patients
Oncotarget Volume 11, Issue 29 reported that acute myeloid leukemia is a heterogeneous malignancy with the most common genomic alterations in NPM1, DNMT3A, and FLT3. (2020-10-14)
Advanced prostate cancer has an unexpected weakness that can be targeted by drugs
Kanazawa University researchers reported that the SUCLA2 gene is frequently involved in the deletion of the tumor suppressor gene RB1 in advanced prostate cancer. (2020-10-07)
New way to halt leukemia relapse shown promising in mice
Drugs tackling chronic myelogenous leukemia have completely transformed prognoses of patients over the last couple of decades, with most cases going into remission. (2020-09-18)
Molecular basis underlying colorectal cancer revealed
A team of scientists has unraveled the molecular mechanism behind one of the causes of colorectal cancer, and a treatment target. (2020-09-15)
CNIO researchers develop an effective strategy against KRAS mutant lung tumors in mice
Researchers achieved complete remission of 25% of lung tumours caused by the KRAS oncogene in mice by inactivating CDK4 and RAF1, two genes that act at different levels in the signalling pathway of this oncogene. (2020-09-08)
Extrachromosomal DNA is common in human cancer and drives poor patients outcomes
The multiplication of genes located in extrachromosomal DNA that have the potential to cause cancer drives poor patient outcomes across many cancer types, according to a Nature Genetics study published Aug. (2020-08-17)
A cancer mystery of more than 40 years ago is solved thanks to epigenetics
In an article that was just published in Proceedings of the National Academy of Sciences (PNAS) by the group of Dr. (2020-08-12)
Study provides new insight on colorectal cancer growth
A new study by researchers at the University of Kentucky identifies a novel function of the enzyme spermine synthase to facilitate colorectal cancer growth. (2020-07-29)
Scientists ID gene responsible for deadly glioblastoma
The discovery of the oncogene responsible for glioblastoma could be the brain cancer's Achilles' heel, one researcher says. (2020-07-14)
St. Jude researchers create an analytic tool that opens a new frontier of cancer discovery
St. Jude Children's Research Hospital scientists have developed software to identify cancer-causing mutations lurking in vast regions of the human genome. (2020-07-06)
NUS researchers uncover a novel protein which drives cancer progression
Researchers from the Cancer Science Institute of Singapore at the National University of Singapore have discovered a protein that drives the progression of esophageal cancer and liver cancer and it could be a promising target for cancer drug development. (2020-06-29)
Researchers find a new therapeutic target in pancreatic cancer
The development of pancreatic cancer is driven by coexisting mutations in an oncogene involved in controlling cell growth, and in a tumor suppressor gene. (2020-06-18)
New treatment target verification for myelodysplastic syndrome
A Japanese research group analyzed the pathophysiology of myelodysplastic syndrome (MDS), a blood cancer that presents often in the elderly, and found the presence of transcription factor RUNX3, thereby revealing a cancer growth function for what had been considered be a tumor suppressor. (2020-06-08)
Virtual cell predicts how close tumor environment influences cancer metastasis
IGC Researchers identify signals emitted by the tumor environment, which controls the migrating capacity of cancer cells. (2020-03-31)
Experimental drug combination shows potential for triple-negative breast cancer
Researchers from Vanderbilt-Ingram Cancer Center discovered a role for MYCN in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further clinical investigation. (2020-03-11)
Towards better anti-cancer drugs
The Bayreuth biochemist Dr. Claus-D. Kuhn and his research team have deciphered how the important human oncogene CDK8 is activated in cells of healthy individuals. (2020-01-28)
Inhibition of p38 reduces the growth of lung tumours
Ángel Nebreda's team has published a study in the journal PNAS reporting the involvement of the protein p38 in the progression of lung cancer. (2020-01-23)
UCLA study shows inhibition of gene helps overcome resistance to immunotherapy
A new study helps explain why some people with advanced cancer may not respond to one of the leading immunotherapies, PD-1 blockade, and how a new combination approach may help overcome resistance to the immunotherapy drug. (2019-12-09)
New candidate cancer genes identified using math models
Computational modeling is the use of computers to simulate and study the behavior of complex systems. (2019-11-15)
Silencing RNA nanotherapy shows promise against pancreatic cancer
Despite advances in cancer survival, more than 90% of people with pancreatic cancer die within five years. (2019-10-21)
A new route to blocking children's bone cancer
A study in mice showed that reducing a particular hormone signal keeps the cancer from growing and spreading. (2019-10-02)
How newly found tension sensor plays integral role in aligned chromosome partitioning
A Waseda University-led research found that oncogene SET/TAF1, which was found to be a proto-oncogene of acute myeloid leukemia (AML), contributes to proper chromosome partitioning as a tension sensor. (2019-09-30)
Gene mutation, tissue location, signaling networks drive cancer incidence and severity
Mutated KRAS genes are commonly found in several cancers and not all KRAS mutations in the same organ tissue cause the same disease severity, according to three new studies from researchers at the Cancer Center at Beth Israel Deaconess Medical Center. (2019-09-11)
Discovered a molecule that regulates the development of cancer in a variety of tumors
Researchers from the Josep Carreras Leukemia Research Institute (IJC), discover that a non-coding region of the genome originates a key molecule for the proliferation of tumors in breast cancer and some types of sarcoma. (2019-09-04)
CRISPR gene editing may halt progression of triple-negative breast cancer
A tumor-targeted CRISPR gene editing system, encapsulated in a nanogel and injected into the body, could effectively and safely halt the growth of triple-negative breast cancer, report researchers at Boston Children's Hospital. (2019-08-26)
Genetically manipulating protein level in colon cancer cells can improve chemotherapy
Colorectal cancer outcomes may improve by genetically altering an immune-regulatory protein in cancer cells, making the cells more vulnerable to chemotherapy. (2019-08-26)
Revealing the molecular engine that drives pancreatic cancer provides ways to turn it off
Researchers have decoded a chain of molecules that are critical for the growth and survival of pancreatic ductal adenocarcinoma -- the most common and also the most lethal form of pancreatic cancer. (2019-08-22)
Explaining why TP53 is commonly mutated in human cancer, and the effects of its mutation
A comprehensive functional analysis of TP53 mutations in human leukemia may refute a working hypothesis -- primarily based on mouse studies -- that missense mutations confer new cancer-causing functions to the p53 tumor suppressor protein; the new study instead suggests that these mutations exert a 'dominant-negative' effect that reduces the cancer-suppressing activity of wild-type p53, the authors say. (2019-08-08)
New anticancer agents may better control tumor growth in nearly every cancer type
Researchers at Purdue University have discovered a novel set of MYC promoter G-quadruplex stabilizers that have demonstrated anticancer activity in human cancer cell cultures. (2019-07-08)
Protein linked to aggressive skin cancer
Almost 300,000 people worldwide develop malignant melanoma each year. The disease is the most serious form of skin cancer and the number of cases reported annually is increasing, making skin cancer one of Sweden's most common forms of cancer. (2019-06-28)
Researchers unlock mysteries of complex microRNA oncogenes
A new collaborative study, led by researchers at McGill University's Goodman Cancer Research Centre (GCRC), and published in the journal Molecular Cell, uncovers novel functions for polycistronic microRNAs and showing how cancers such as lymphoma twist these functions to reorganize the information networks that control gene expression. (2019-06-27)
Newly defined cancer driver is fast, furious and loud
A new study from researchers at the University of Michigan Rogel Cancer Center finds that the gene FOXA1 overrides normal biology in three different ways to drive prostate cancer. (2019-06-26)
Long thought harmless, a glycan biomarker may cause pancreatic disease and cancer
A widely recognized biomarker for pancreatic disease, CA19-9, thought to be benign for decades, may in fact be a promoter for the development of these diseases, including pancreatic cancer. (2019-06-20)
Not silent at all
The so-called 'silent' or 'synonymous' genetic alterations do not result in altered proteins. (2019-06-12)
CNIO participates in a study identifying a novel oncogene for most common types of blood cancer
The study shows that tumour suppressor hnRNP K can lead to cancer. (2019-05-24)
Enzyme PHLPP2 could be a viable drug target for treating prostate cancer
Researchers propose a new druggable target that can put a damper on the spread of prostate cancer. (2019-05-15)
New study explains how inflammation causes gastric cancer
Researchers from Kanazawa University and the Japan Agency for Medical Research and Development have solved the decades-old mystery of how stomach bacterium Helicobacter pylori causes gastric cancer. (2019-04-16)
New gene hunt reveals potential breast cancer treatment target
Australian and US researchers have developed a way to discover elusive cancer-promoting genes, already identifying one that appears to promote aggressive breast cancers. (2019-03-08)
Yeast study prompts rethink of DNA safekeeping
DNA replication is more prone to errors at times of stress leading to mutations that could cause disease. (2019-02-04)
MD Anderson study shows FGL2 protein may be an effective target for glioblastoma
Glioblastoma (GBM) does not attract robust T cell immune responses. (2019-01-25)
Page 1 of 14 | 522 Results
   First   Previous   Next      Last   

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.